(ZHE) — Having successfully closed on its $66 billion purchase of the agrochemical company Monsanto in June, we suspect Germany’s Bayer AG, is more than a little concerned now after failing to persuade a judge to set aside a jury’s $289 million verdict in the first trial over allegations that its Roundup weed killer causes cancer. As […]
Source